CN Patent

CN121015618A — 一种稠合三环γ-氨基酸衍生物的缓释药物制剂及其制备方法

Assigned to Sichuan Haisco Pharmaceutical Co Ltd · Expires 2025-11-28 · 0y expired

What this patent protects

本发明涉及一种稠合三环γ‑氨基酸衍生物的缓释药物制剂及其制备方法。所述稠合三环γ‑氨基酸衍生物为式(I)所示的化合物或者其立体异构体、溶剂化物、前药、代谢产物、药学上可接受的盐或共晶。

USPTO Abstract

本发明涉及一种稠合三环γ‑氨基酸衍生物的缓释药物制剂及其制备方法。所述稠合三环γ‑氨基酸衍生物为式(I)所示的化合物或者其立体异构体、溶剂化物、前药、代谢产物、药学上可接受的盐或共晶。

Drugs covered by this patent

Patent Metadata

Patent number
CN121015618A
Jurisdiction
CN
Classification
—
Expires
2025-11-28
Drug substance claim
No
Drug product claim
No
Assignee
Sichuan Haisco Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.